| Product Code: ETC9507785 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname ceftriaxone import market continues to be dominated by exporters from the Netherlands and the United Kingdom in 2024. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, with limited competition among suppliers. The impressive compound annual growth rate (CAGR) of 22.21% from 2020 to 2024 reflects sustained demand for ceftriaxone in Suriname. Moreover, the growth rate of 8.52% in 2024 demonstrates a positive momentum in the market, suggesting potential opportunities for both exporters and local distributors to capitalize on the increasing demand for this essential medication.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Ceftriaxone Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Ceftriaxone Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Ceftriaxone Market - Industry Life Cycle |
3.4 Suriname Ceftriaxone Market - Porter's Five Forces |
3.5 Suriname Ceftriaxone Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Suriname Ceftriaxone Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Ceftriaxone Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Suriname |
4.2.2 Growing awareness about the effectiveness of ceftriaxone in treating various infections |
4.2.3 Rising healthcare expenditure and investments in healthcare infrastructure in Suriname |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and sale of pharmaceutical products |
4.3.2 Competition from alternative antibiotics and generic ceftriaxone products |
4.3.3 Limited access to advanced healthcare facilities in remote areas of Suriname |
5 Suriname Ceftriaxone Market Trends |
6 Suriname Ceftriaxone Market, By Types |
6.1 Suriname Ceftriaxone Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Suriname Ceftriaxone Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Suriname Ceftriaxone Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.1.4 Suriname Ceftriaxone Market Revenues & Volume, By Intra-abdominal Infections, 2021- 2031F |
6.1.5 Suriname Ceftriaxone Market Revenues & Volume, By Endocarditis, 2021- 2031F |
6.1.6 Suriname Ceftriaxone Market Revenues & Volume, By Acute Bacterial Otitis Media, 2021- 2031F |
6.1.7 Suriname Ceftriaxone Market Revenues & Volume, By Meningitis, 2021- 2031F |
6.1.8 Suriname Ceftriaxone Market Revenues & Volume, By Pneumonia, 2021- 2031F |
6.2 Suriname Ceftriaxone Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Suriname Ceftriaxone Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Suriname Ceftriaxone Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.4 Suriname Ceftriaxone Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Suriname Ceftriaxone Market Import-Export Trade Statistics |
7.1 Suriname Ceftriaxone Market Export to Major Countries |
7.2 Suriname Ceftriaxone Market Imports from Major Countries |
8 Suriname Ceftriaxone Market Key Performance Indicators |
8.1 Rate of antibiotic-resistant bacterial infections in Suriname |
8.2 Number of healthcare professionals prescribing ceftriaxone |
8.3 Percentage of hospitals and clinics stocking ceftriaxone consistently |
8.4 Level of patient satisfaction with ceftriaxone treatment outcomes |
8.5 Frequency of ceftriaxone stockouts or shortages in Suriname |
9 Suriname Ceftriaxone Market - Opportunity Assessment |
9.1 Suriname Ceftriaxone Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Suriname Ceftriaxone Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Ceftriaxone Market - Competitive Landscape |
10.1 Suriname Ceftriaxone Market Revenue Share, By Companies, 2024 |
10.2 Suriname Ceftriaxone Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here